Lymph-Venous Anastomosis for Breast Cancer-Related Lymphoedema after Docetaxel-Based Chemotherapy

Docetaxel-based chemotherapy, which is administered before or after axillary lymph node dissection (ALND) in breast cancer patients with positive axillary lymph nodes, is reported as an independent risk factor for development of breast cancer-related lymphoedema (BCRL). Severe hardening of the soft...

Full description

Bibliographic Details
Main Authors: Yuma Fuse, Ryo Karakawa, Tomoyuki Yano, Hidehiko Yoshimatsu
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/5/1409
_version_ 1797474701773111296
author Yuma Fuse
Ryo Karakawa
Tomoyuki Yano
Hidehiko Yoshimatsu
author_facet Yuma Fuse
Ryo Karakawa
Tomoyuki Yano
Hidehiko Yoshimatsu
author_sort Yuma Fuse
collection DOAJ
description Docetaxel-based chemotherapy, which is administered before or after axillary lymph node dissection (ALND) in breast cancer patients with positive axillary lymph nodes, is reported as an independent risk factor for development of breast cancer-related lymphoedema (BCRL). Severe hardening of the soft tissue, which is a typical manifestation of BCRL with a history of docetaxel-based chemotherapy, has been considered a contraindication for lymph-venous anastomosis (LVA). This study aimed to evaluate the efficacy of LVA for BCRL with a history of the use of docetaxel. Twenty-six consecutive BCRL patients who underwent LVA were reviewed retrospectively. All patients underwent ALND. Amongst 23 patients who had chemotherapy for breast cancer, docetaxel-based chemotherapy was administered in 12 patients. The postoperative change of the limb circumferences and the improvement of subjective symptoms were assessed. Overall, patients showed improvements of the limb circumferences at the wrist, the elbow, and 5 cm above and below the elbow. There were no statistical differences of the postoperative changes of the circumferences between the docetaxel-administered and non-administered groups (0.25% vs. 2.8% at 5 cm above the elbow (<i>p</i> = 0.23), −0.4% vs. 0.7% at 5 cm below the elbow (<i>p</i> = 0.56), and 2.5% vs. 2.5 % at the wrist (<i>p</i> = 0.82)). LVA is comparably effective for lymphedematous patients who had undergone docetaxel-based chemotherapy before or after ALND.
first_indexed 2024-03-09T20:33:56Z
format Article
id doaj.art-4e806dc07057454abe4ad3f8e753ef0d
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T20:33:56Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-4e806dc07057454abe4ad3f8e753ef0d2023-11-23T23:15:28ZengMDPI AGJournal of Clinical Medicine2077-03832022-03-01115140910.3390/jcm11051409Lymph-Venous Anastomosis for Breast Cancer-Related Lymphoedema after Docetaxel-Based ChemotherapyYuma Fuse0Ryo Karakawa1Tomoyuki Yano2Hidehiko Yoshimatsu3Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo 135-8550, JapanDepartment of Plastic and Reconstructive Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo 135-8550, JapanDepartment of Plastic and Reconstructive Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo 135-8550, JapanDepartment of Plastic and Reconstructive Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo 135-8550, JapanDocetaxel-based chemotherapy, which is administered before or after axillary lymph node dissection (ALND) in breast cancer patients with positive axillary lymph nodes, is reported as an independent risk factor for development of breast cancer-related lymphoedema (BCRL). Severe hardening of the soft tissue, which is a typical manifestation of BCRL with a history of docetaxel-based chemotherapy, has been considered a contraindication for lymph-venous anastomosis (LVA). This study aimed to evaluate the efficacy of LVA for BCRL with a history of the use of docetaxel. Twenty-six consecutive BCRL patients who underwent LVA were reviewed retrospectively. All patients underwent ALND. Amongst 23 patients who had chemotherapy for breast cancer, docetaxel-based chemotherapy was administered in 12 patients. The postoperative change of the limb circumferences and the improvement of subjective symptoms were assessed. Overall, patients showed improvements of the limb circumferences at the wrist, the elbow, and 5 cm above and below the elbow. There were no statistical differences of the postoperative changes of the circumferences between the docetaxel-administered and non-administered groups (0.25% vs. 2.8% at 5 cm above the elbow (<i>p</i> = 0.23), −0.4% vs. 0.7% at 5 cm below the elbow (<i>p</i> = 0.56), and 2.5% vs. 2.5 % at the wrist (<i>p</i> = 0.82)). LVA is comparably effective for lymphedematous patients who had undergone docetaxel-based chemotherapy before or after ALND.https://www.mdpi.com/2077-0383/11/5/1409breast cancer-related lymphedemalymph-venous anastomosisdocetaxel-based chemotherapy
spellingShingle Yuma Fuse
Ryo Karakawa
Tomoyuki Yano
Hidehiko Yoshimatsu
Lymph-Venous Anastomosis for Breast Cancer-Related Lymphoedema after Docetaxel-Based Chemotherapy
Journal of Clinical Medicine
breast cancer-related lymphedema
lymph-venous anastomosis
docetaxel-based chemotherapy
title Lymph-Venous Anastomosis for Breast Cancer-Related Lymphoedema after Docetaxel-Based Chemotherapy
title_full Lymph-Venous Anastomosis for Breast Cancer-Related Lymphoedema after Docetaxel-Based Chemotherapy
title_fullStr Lymph-Venous Anastomosis for Breast Cancer-Related Lymphoedema after Docetaxel-Based Chemotherapy
title_full_unstemmed Lymph-Venous Anastomosis for Breast Cancer-Related Lymphoedema after Docetaxel-Based Chemotherapy
title_short Lymph-Venous Anastomosis for Breast Cancer-Related Lymphoedema after Docetaxel-Based Chemotherapy
title_sort lymph venous anastomosis for breast cancer related lymphoedema after docetaxel based chemotherapy
topic breast cancer-related lymphedema
lymph-venous anastomosis
docetaxel-based chemotherapy
url https://www.mdpi.com/2077-0383/11/5/1409
work_keys_str_mv AT yumafuse lymphvenousanastomosisforbreastcancerrelatedlymphoedemaafterdocetaxelbasedchemotherapy
AT ryokarakawa lymphvenousanastomosisforbreastcancerrelatedlymphoedemaafterdocetaxelbasedchemotherapy
AT tomoyukiyano lymphvenousanastomosisforbreastcancerrelatedlymphoedemaafterdocetaxelbasedchemotherapy
AT hidehikoyoshimatsu lymphvenousanastomosisforbreastcancerrelatedlymphoedemaafterdocetaxelbasedchemotherapy